|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-5-25
|
|
pubmed:abstractText |
The natural history of stroke is worse in women than in men. Controversial data have been published on the efficacy of thrombolysis with recombinant tissue plasminogen activator (rtPA) according to gender. We evaluated gender differences in the efficacy and safety outcomes of intravenous rtPA using a clinical registry and systematic review.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1524-4628
|
|
pubmed:author |
pubmed-author:AbboudHalimH,
pubmed-author:AmarencoPierreP,
pubmed-author:ArnaizCarlosC,
pubmed-author:CabrejoLucieL,
pubmed-author:GuidouxCelineC,
pubmed-author:KleinIsabelle FIF,
pubmed-author:LabreucheJulienJ,
pubmed-author:LapergueBertrandB,
pubmed-author:LavalléePhilippa CPC,
pubmed-author:MazighiMikaelM,
pubmed-author:MeseguerElenaE,
pubmed-author:OlivotJean-MarcJM,
pubmed-author:RaphaeliGuyG,
pubmed-author:SlaouiTarikT
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2104-10
|
|
pubmed:meshHeading |
pubmed-meshheading:19372440-Aged,
pubmed-meshheading:19372440-Data Interpretation, Statistical,
pubmed-meshheading:19372440-Female,
pubmed-meshheading:19372440-Fibrinolytic Agents,
pubmed-meshheading:19372440-Humans,
pubmed-meshheading:19372440-Injections, Intravenous,
pubmed-meshheading:19372440-Male,
pubmed-meshheading:19372440-Middle Aged,
pubmed-meshheading:19372440-Prospective Studies,
pubmed-meshheading:19372440-Recombinant Proteins,
pubmed-meshheading:19372440-Registries,
pubmed-meshheading:19372440-Sex Factors,
pubmed-meshheading:19372440-Stroke,
pubmed-meshheading:19372440-Tissue Plasminogen Activator,
pubmed-meshheading:19372440-Tomography, X-Ray Computed,
pubmed-meshheading:19372440-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review.
|
|
pubmed:affiliation |
INSERM U-698 and Paris-Diderot University, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|
